Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Travera Inc
Seagen Inc.
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
AstraZeneca
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb
Filamon LTD
Hoffmann-La Roche
Psyence Australia Pty Ltd
ViroMissile, Inc.
Erasca, Inc.
Dana-Farber Cancer Institute
Arvinas Inc.
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Icahn School of Medicine at Mount Sinai
St. Jude Children's Research Hospital
MacroGenics
City of Hope Medical Center
xCures
Daiichi Sankyo
University of Nebraska